These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 17510116)

  • 1. Misuse of confidence intervals threatens conclusions.
    Cates CJ
    BMJ; 2007 May; 334(7602):1020. PubMed ID: 17510116
    [No Abstract]   [Full Text] [Related]  

  • 2. Beta blockers in hypertension and cardiovascular disease.
    Ong HT
    BMJ; 2007 May; 334(7600):946-9. PubMed ID: 17478848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are beta blockers effective first-line treatments for hypertension?
    Cayley WE
    Am Fam Physician; 2007 Nov; 76(9):1306-8. PubMed ID: 18019872
    [No Abstract]   [Full Text] [Related]  

  • 4. Current role of beta-blockers in the treatment of hypertension.
    Aronow WS
    Expert Opin Pharmacother; 2010 Nov; 11(16):2599-607. PubMed ID: 20426702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Resp-informations].
    Bouvier-Colle MH; Cot M; Le Goaster C
    Rev Epidemiol Sante Publique; 2000 Apr; 48(2):215-24. PubMed ID: 10804430
    [No Abstract]   [Full Text] [Related]  

  • 6. Beta-blockers and hypertension.
    Cruickshank JM
    J Am Coll Cardiol; 2009 Jun; 53(22):2105-6; author reply 2106-7. PubMed ID: 19477369
    [No Abstract]   [Full Text] [Related]  

  • 7. Beta blockers as cardioprotective agents: Part II--Focus on prevention of sudden cardiac death.
    Goldstein S
    Am J Manag Care; 2002 Jun; 8(9 Suppl):18-24. PubMed ID: 12099324
    [No Abstract]   [Full Text] [Related]  

  • 8. [Large-scale trials in hypertension: clinical relevance and evaluation].
    Tsukiyama H; Okada K
    Nihon Rinsho; 2006 Aug; 64 Suppl 6():387-95. PubMed ID: 16981569
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of losartan compared with atenolol on the incidence of revascularization in patients with hypertension and electrocardiographic left ventricular hypertrophy. The LIFE study.
    Olsen MH; Wachtell K; Dahlöf B; Devereux RB; Ibsen H; Kjeldsen SE; Lindholm LH; Lyle PA; Nieminen MS
    J Hum Hypertens; 2006 Jun; 20(6):460-4. PubMed ID: 16572193
    [No Abstract]   [Full Text] [Related]  

  • 10. Beta-blocker-induced heart rate lowering, cardioprotection, and hypertension.
    Khan SS
    J Am Coll Cardiol; 2009 Jun; 53(22):2104-5; author reply 2106-7. PubMed ID: 19477368
    [No Abstract]   [Full Text] [Related]  

  • 11. Atenolol is dead: long live beta-blockade.
    Cockcroft JR
    J Am Coll Cardiol; 2009 Jun; 53(22):2102; author reply 2106-7. PubMed ID: 19477365
    [No Abstract]   [Full Text] [Related]  

  • 12. Beta-blockers as first-line antihypertensive therapy the crumbling continues.
    Lavie CJ; Messerli FH; Milani RV
    J Am Coll Cardiol; 2009 Sep; 54(13):1162-4. PubMed ID: 19761937
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hypertension in the elderly].
    Ogihara T
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():394-8. PubMed ID: 15171406
    [No Abstract]   [Full Text] [Related]  

  • 14. Beta-blocker-induced heart rate reduction: too simplistic to explain the deleterious effects of beta-blockers.
    Laurent S; Boutouyrie P
    J Am Coll Cardiol; 2009 Jun; 53(22):2103-4; author reply 2106-7. PubMed ID: 19477367
    [No Abstract]   [Full Text] [Related]  

  • 15. Different metabolic effects of selective and nonselective beta-blockers rather than mere heart rate reduction may be the mechanisms by which beta-blockade prevents cardiovascular events.
    Fragasso G; Cera M; Margonato A
    J Am Coll Cardiol; 2009 Jun; 53(22):2105; author reply 2106-7. PubMed ID: 19477370
    [No Abstract]   [Full Text] [Related]  

  • 16. Which antihypertensive drugs first--and why!
    Alderman MH
    JAMA; 1992 May; 267(20):2786-7. PubMed ID: 1349655
    [No Abstract]   [Full Text] [Related]  

  • 17. [ASCOT Study of optimal hypertension therapy. New study results against the "diuretics first" recommendation].
    MMW Fortschr Med; 2005 Dec; 147(49-50):66-7. PubMed ID: 16402454
    [No Abstract]   [Full Text] [Related]  

  • 18. Hypertension in an urban population--who is treated with what and how well?
    Li C; Hedblad B; Berglund G; Janzon L
    J Hum Hypertens; 2007 Apr; 21(4):323-6. PubMed ID: 17273156
    [No Abstract]   [Full Text] [Related]  

  • 19. [Classification and risk stratification in hypertension Recommendations of the European Society for Hypertension (ESH)].
    Zidek W
    MMW Fortschr Med; 2003 Nov; 145(45):41-2. PubMed ID: 14699807
    [No Abstract]   [Full Text] [Related]  

  • 20. Are new antihypertensive agents better than old antihypertensive agents in preventing cardiovascular complications?
    Dickerson LM; Carek PJ
    J Fam Pract; 2002 Jan; 51(1):9. PubMed ID: 11927051
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.